Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Langel

Showing results (61-70 of 565) with videos related to

Pageof 57
Sort By:
CSH Protocols|March 2, 2011
Cell-Penetrating Peptide-Mediated Delivery of Peptide Nucleic Acid (PNA) OligomersPontus Lundberg, Kalle Kilk, Ulo Langel
Cellular and Molecular Neurobiology|December 1, 1995
Galanin--a neuropeptide with inhibitory actionsK Kask, U Langel, T Bartfai
Neuropeptides|June 10, 2005
Galnon--a low-molecular weight ligand of the galanin receptorsUlla Sollenberg, Tamas Bartfai, Ulo Langel
Pharmaceutics|June 27, 2024
A Physiologically Based Pharmacokinetic (PBPK) Study to Assess the Adjuvanticity of Three Peptides in an Oral VaccineLeonor Saldanha, Ülo Langel, Nuno Vale
Brain Research|September 6, 1991
Hypothalamic degradation of galanin(1-29) and galanin(1-16): identification and characterization of the peptidolytic productsT Land, U Langel, T Bartfai
Biochimica Et Biophysica Acta|July 1, 2006
Structure-activity relationship study of the cell-penetrating peptide pVECAnna Elmquist, Mats Hansen, Ulo Langel
Therapeutic Delivery|May 8, 2013
Therapeutic potential of cell-penetrating peptidesLuís Vasconcelos, Kalle Pärn, Ulo Langel
Bioconjugate Chemistry|January 18, 2007
Protein delivery by the cell-penetrating peptide YTA2Helena Myrberg, Maria Lindgren, Ulo Langel
Expert Opinion on Drug Delivery|December 5, 2015
Recent in vivo advances in cell-penetrating peptide-assisted drug deliveryKaido Kurrikoff, Maxime Gestin, Ülo Langel
Science Immunology|June 5, 2023
Antibody-mediated immunity against lung cancer goes retroStephanie N Langel, David R Martinez
Pageof 57

Showing results (61-70 of 565) with videos related to

Sort By:
Pageof 57
CSH Protocols|March 2, 2011
Cell-Penetrating Peptide-Mediated Delivery of Peptide Nucleic Acid (PNA) OligomersPontus Lundberg, Kalle Kilk, Ulo Langel
Cellular and Molecular Neurobiology|December 1, 1995
Galanin--a neuropeptide with inhibitory actionsK Kask, U Langel, T Bartfai
Neuropeptides|June 10, 2005
Galnon--a low-molecular weight ligand of the galanin receptorsUlla Sollenberg, Tamas Bartfai, Ulo Langel
Pharmaceutics|June 27, 2024
A Physiologically Based Pharmacokinetic (PBPK) Study to Assess the Adjuvanticity of Three Peptides in an Oral VaccineLeonor Saldanha, Ülo Langel, Nuno Vale
Brain Research|September 6, 1991
Hypothalamic degradation of galanin(1-29) and galanin(1-16): identification and characterization of the peptidolytic productsT Land, U Langel, T Bartfai
Biochimica Et Biophysica Acta|July 1, 2006
Structure-activity relationship study of the cell-penetrating peptide pVECAnna Elmquist, Mats Hansen, Ulo Langel
Therapeutic Delivery|May 8, 2013
Therapeutic potential of cell-penetrating peptidesLuís Vasconcelos, Kalle Pärn, Ulo Langel
Bioconjugate Chemistry|January 18, 2007
Protein delivery by the cell-penetrating peptide YTA2Helena Myrberg, Maria Lindgren, Ulo Langel
Expert Opinion on Drug Delivery|December 5, 2015
Recent in vivo advances in cell-penetrating peptide-assisted drug deliveryKaido Kurrikoff, Maxime Gestin, Ülo Langel
Science Immunology|June 5, 2023
Antibody-mediated immunity against lung cancer goes retroStephanie N Langel, David R Martinez
Pageof 57